A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
Public ClinicalTrials.gov record NCT00831129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to examine if a combination of a cholesterol lowering-drug, simvastatin, with a sugar-lowering drug called rosiglitazone is more effective in improving vascular inflammation (irritation of the vessels that transport your blood) and other cardiovascular risk factors than the taking of simvastatin alone.
Study identification
- NCT ID
- NCT00831129
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Feb 28, 2011
- Completion
- Mar 31, 2011
- Last update posted
- Feb 9, 2017
2006 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pre-diabetes trials
Other public records listing Pre-diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07167004: The GRoceries Aimed at Increasing Nutrition Study Recruiting
- NCT06607341: Community Engagement Alliance Against Disparities Active, not recruiting
- NCT05585190: Stand up for Your Health With a Sit-stand Desk Recruiting
- NCT06387797: Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County Active, not recruiting
- NCT04234217: Mechanisms of Prediabetic States in Sleep Apnea Active, not recruiting
- NCT04168372: Fructose: Substrate, Stimulus, or Both? Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00831129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00831129 live on ClinicalTrials.gov.